4.7 Article

Increased Risk of Severe Depression in Male Partners of Women With Breast Cancer

Journal

CANCER
Volume 116, Issue 23, Pages 5527-5534

Publisher

WILEY-BLACKWELL
DOI: 10.1002/cncr.25534

Keywords

affective disorder; breast cancer; cohort study; Denmark; depression; partners

Categories

Funding

  1. Japan Society for the Promotion of Science (Japan)
  2. Foundation for Promotion of Cancer Research (Japan)
  3. Southern Danish University
  4. Danish Cancer Society (Denmark)

Ask authors/readers for more resources

BACKGROUND: A few small studies published to date have suggested that major psychosocial problems develop in the partners of cancer patients; however, to the authors' knowledge, no studies to date have addressed their risk for severe depression. In a retrospective cohort study, the risk for hospitalization with an affective disorder of the male partners of women with breast cancer was investigated, using unbiased, nationwide, population-based information. METHODS: Followed were 1,162,596 men born between 1925 and 1973 who were aged >= 30 years at study entry, resided in Denmark between 1994 and 2006, had no history of hospitalization for an affective disorder, and had lived continuously with the same partner for at least 5 years. A Cox regression analysis included detailed clinical information regarding the diagnosis and treatment of breast cancer and on annually updated socioeconomic and health-related indicators obtained from national administrative and disease registers. RESULTS: During the 13 years of follow-up, breast cancer was diagnosed in the partners of 20,538 men. On multivariable analysis, men whose partner was diagnosed with breast cancer were found to be at an increased risk of being hospitalized with an affective disorder (hazards ratio, 1.39; 95%confidence interval, 1.20-1.61), with a dose-response pattern for the severity of breast cancer. Furthermore, men whose partner died after breast cancer had a significant, 3.6-fold increase in risk for an affective disorder when compared with men whose partner survived breast cancer. CONCLUSIONS: The results of the current study supported the hypothesis that men whose partner had breast cancer were at an increased risk for hospitalization with an affective disorder. Cancer 2010;116:5527-34. (C) 2070 American Cancer Society

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy

Sidsel Pedersen, Rikke B. B. Holmstroem, Annika von Heymann, Laerke K. K. Tolstrup, Kasper Madsen, Morten Aagaard Petersen, Charlotte A. A. Haslund, Christina H. H. Ruhlmann, Henrik Schmidt, Christoffer Johansen, Inge Marie Svane, Eva Ellebaek

Summary: This study investigates the impact of adjuvant immunotherapy on health-related quality of life (HRQoL) in patients with resected melanoma. The findings suggest that HRQoL is lowest in patients who ended therapy 0-6 months ago and that fatigue is more severe in this group. Patients in active treatment for >6 months also have lower HRQoL and more fatigue compared to those who started treatment 0-6 months ago. However, patients who ended therapy >6 months ago have higher HRQoL and less fatigue. HRQoL is associated with treatment status, comorbidity, civil status, and employment status.

ACTA ONCOLOGICA (2023)

Article Oncology

Lung cancer registries in Denmark, Finland, Norway and Sweden: a comparison and proposal for harmonization

A. Gouliaev, T. R. Rasmussen, N. Malila, L. Fjellbirkeland, L. Lofling, E. Jakobsen, S. O. Dalton, N. L. Christensen

Summary: This paper describes and compares the characteristics of lung cancer registry data in Denmark, Finland, Norway, and Sweden, and discusses how a more harmonized registration practice could increase their usefulness for mutual learning and quality improvement.

ACTA ONCOLOGICA (2023)

Article Oncology

Effects on long-term survival of psychosocial group intervention in early-stage breast cancer: follow-up of a randomized controlled trial

Anne Marie Kirkegaard, Susanne Oksbjerg Dalton, Ellen Helle Boesen, Randi V. Karlsen, Henrik Flyger, Christoffer Johansen, Annika von Heymann

Summary: This study investigated the impact of a psychosocial group intervention on long-term survival in women with early-stage breast cancer and compared the characteristics and survival between study participants and non-participants. The results showed that the psychosocial intervention did not significantly improve survival in the intervention group. Participants had higher survival rates than non-participants, but this difference was more attributed to clinical and demographic characteristics rather than study participation.

ACTA ONCOLOGICA (2023)

Article Oncology

Are education and cohabitation associated with health-related quality of life and self-management during breast cancer follow-up? A longitudinal study

Randi V. Karlsen, Beverley Lim Hoeg, Susanne Oksbjerg Dalton, Lena Saltbaek, Christian Dehlendorff, Christoffer Johansen, Mads Nordahl Svendsen, Pernille E. Bidstrup

Summary: This study examined whether recent socioeconomic factors were associated with health-related quality of life (HRQoL) and self-management in breast cancer patients. The results showed that socioeconomic factors did influence HRQoL, especially within the first five years after diagnosis, specifically in terms of experiencing and reporting relevant symptoms of concern.

ACTA ONCOLOGICA (2023)

Review Oncology

Sarcopenia and loss of muscle mass in patients with lung cancer undergoing chemotherapy treatment: a systematic review and meta-analysis

Sandra Jensen, Zina Bloch, Morten Quist, Tobias Tuse Dunk Hansen, Christoffer Johansen, Helle Pappot, Charlotte Suetta, Bolette Skjodt Rafn

Summary: In patients with lung cancer, chemotherapy treatment leads to significant loss of skeletal muscle mass and a high prevalence of sarcopenia. This is associated with poor clinical outcomes and emphasizes the need for assessment and interventions targeting skeletal muscle mass during treatment.

ACTA ONCOLOGICA (2023)

Article Oncology

Physical and psychological symptom burden in patients and caregivers during follow-up care after curative surgery for cancers in the pancreas, bile ducts or duodenum

Kristine Elberg Dengso, Thordis Thomsen, Bo Marcel Christensen, Carina Lund Sorensen, Michael Galanakis, Susanne Oksbjerg Dalton, Jens Hillingso

Summary: This study aimed to assess Health Related Quality of Life (HRQoL), anxiety and depression in patients and caregivers during follow-up care after curative treatment for cancer in the pancreas, duodenum, or bile ducts. The study also highlighted the need to systematically screen physical and psychological symptoms in patients and caregivers during follow-up care and prioritize symptom management by clinicians.

ACTA ONCOLOGICA (2023)

Article Oncology

Earlier Recurrence Detection Using Routine FDG PET-CT Scans in Surveillance of Stage IIB to IIID Melanoma: A National Cohort Study of 1480 Patients

Neel Maria Helvind, Marie Brinch-Moller Weitemeyer, Annette Hougaard Chakera, Helle Westergren Hendel, Eva Ellebaek, Inge Marie Svane, Mette Wanscher Kjaerskov, Sophie Bojesen, Helle Skyum, Soren Kjaer Petersen, Lars Bastholt, Christoffer Johansen, Pernille Envold Bidstrup, Lisbet Rosenkrantz Holmich

Summary: This study aimed to determine the impact of surveillance with routine FDG PET-CT on hazard, cumulative incidence, and absolute risk of overall, locoregional, and distant recurrence detection in patients with stage IIB to IIID cutaneous melanoma. The study found that patients with stage IIB to IIID melanoma followed with routine FDG PET-CT had a 51% increased hazard of distant recurrence detection within the first two years of surveillance.

ANNALS OF SURGICAL ONCOLOGY (2023)

Article Health Care Sciences & Services

Educational differences in healthcare use among survivors after breast, prostate, lung, and colon cancer - a SEQUEL cohort study

Anne Katrine Graudal Levinsen, Trille Kristina Kjaer, Thomas Maltesen, Erik Jakobsen, Ismail Gogenur, Michael Borre, Peer Christiansen, Robert Zachariae, Soren Laurberg, Peter Christensen, Niels Kroman, Signe Benzon Larsen, Thea Helene Degett, Lisbet Rosenkrantz Holmich, Peter de Nully Brown, Christoffer Johansen, Susanne K. Kjaer, Lau Caspar Thygesen, Susanne Oksbjerg Dalton

Summary: Cancer survivors use more healthcare services compared to cancer-free individuals. There is a correlation between educational level and healthcare use, with survivors with lower education being more likely to use general practitioner and acute healthcare services.

BMC HEALTH SERVICES RESEARCH (2023)

Article Oncology

Smoking as a prognostic factor for survival in patients with disseminated germ cell cancer

Mikkel Bandak, Kristine Skovly Nielsen, Michael Kreiberg, Thomas Wagner, Josephine Rosenvilde, Charlotta Pissinger, Christoffer Johansen, Gedske Daugaard, Jakob Lauritsen

Summary: We examined the effects of smoking on the overall survival (OS) of testicular germ cell cancer (TC) patients who received first-line combination chemotherapy (BEP). Using the Danish Testicular Cancer database, we identified patients who underwent BEP for metastatic TC. Information on smoking status at diagnosis was obtained through medical record review. OS and cause of death were compared between current smokers and never-smokers. Of the 1883 eligible patients, smoking status was available for 1156 patients, with 602 being current smokers. The 10-year OS rate was 92% for never-smokers and 83% for current smokers (P < .001), with a hazard ratio for death of 1.85 (95% confidence interval = 1.29 to 2.66, P = .001). A higher proportion of current smokers died from TC compared to nonsmokers (P < .01). Smoking negatively impacts survival after BEP in patients with disseminated TC, highlighting the need for vigorous smoking cessation programs in TC patients.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Oncology

Effects of an early intervention with Hyperbaric Oxygen Treatment on arm lymphedema and quality of life after breast cancer-an explorative clinical trial

Gunn Ammitzboll, Ole Hyldegaard, Martin Forchhammer, Henrik Rottensten, Charlotte Lanng, Niels Kroman, Bo Zerahn, Lars Thorbjorn Jensen, Christoffer Johansen, Susanne Oksbjerg Dalton

Summary: This study aimed to explore the effects of Hyperbaric Oxygen Treatment (HBOT) on early breast cancer-related lymphedema (LE) and its implications for quality of life (QOL). In a prospective observational study, participants receiving 40 sessions of HBOT over 8 weeks were followed for 6 months. While there were no consistent changes in objective measures of LE severity, participants reported significant improvements in QOL.

SUPPORTIVE CARE IN CANCER (2023)

Article Oncology

Impact of previous depression on the risk of suicide among prostate cancer patients

Anne Sofie Friberg, Sigrid V. V. Carlsson, Andrew J. J. Vickers, Susanne Oksbjerg Dalton, Signe Benzon Larsen, Lena Saltbaek, Beverley Lim Hoeg, Pernille Envold Bidstrup, Thomas Helgstrand, Andreas Roder, Klaus Brasso, Christoffer Johansen

Summary: The study examined the risk of suicide among prostate cancer patients compared to cancer-free men, taking into consideration clinical stage, socioeconomic position, somatic comorbidity, and previous depression. The risk of suicide was found to be similar between prostate cancer patients and cancer-free men, but it was highest within the first year after diagnosis. Prostate cancer patients with a history of depression had a higher risk of suicide. Healthcare professionals should pay attention to the risk of suicide among men with previous depression following a prostate cancer diagnosis.

ACTA ONCOLOGICA (2023)

Article Oncology

Feasibility of Using Wearables for Home Monitoring during Radiotherapy for Head and Neck Cancer-Results from the OncoWatch 1.0 Study

Cecilie Hollaender-Mieritz, Emma Balch Steen-Olsen, Claus Andrup Kristensen, Christoffer Johansen, Ivan Richter Vogelius, Helle Pappot

Summary: Consumer wearables, such as smartwatches, can monitor health data and may be useful in the clinical care of cancer patients. The OncoWatch 1.0 study investigated the feasibility of using a smartwatch to monitor heart rate and physical activity in patients with head and neck cancer receiving radiotherapy. Although adherence to wearing the smartwatch was lower than expected, important findings were made regarding data setup and considerations for future studies.

CANCERS (2023)

Article Oncology

Machine learning applied in patient-reported outcome research-exploring symptoms in adjuvant treatment of breast cancer

Helle Pappot, Benony P. Bjoernsson, Oswin Krause, Christina Baeksted, Pernille E. Bidstrup, Susanne O. Dalton, Christoffer Johansen, Ann Knoop, Ivan Vogelius, Cecilie Hollander-Mieritz

Summary: By analyzing ePRO data using Machine Learning algorithms and permutation importance, this study found that symptoms such as aching joints and numbness/tingling may be important factors leading to nonadherence to planned adjuvant chemotherapy in breast cancer patients.

BREAST CANCER (2023)

No Data Available